Overview: Entamoeba TestIntroduction: The Entamoeba Test detects Entamoeba parasites causing amoebiasis, leading to diarrhea or abdominal pain, helping diagnose and treat gastrointestinal infections. Affecting 1 in 10,000 travelers annually, amoebiasis poses diagnostic challenges due to waterborne transmission. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses microscopy/PCR for high accuracy, supporting parasitology screening. This test is vital for diagnosis, treatment planning, and improving outcomes in infectious disease management.
Other Names: Entamoeba Detection Test, Amoebiasis Assay.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic reliability.
Historical Milestone: Parasite testing began in the 1920s with research by Dobell, who identified Entamoeba. PCR advancements in the 2000s by Roche improved detection, surpassing earlier microscopy methods.
Purpose: Detects Entamoeba to diagnose amoebiasis, guides antiparasitic therapy, and evaluates patients with diarrhea, aiming to resolve infection.
Test Parameters: Entamoeba presence
Pretest Condition: Fresh stool sample required. Collect sample. Report history of gastrointestinal symptoms.
Specimen: Stool (sterile container, 5-10 gm); Stool in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document diarrhea or abdominal pain. Include current medications or travel history.
Consent: Written consent required, detailing the test's purpose, infection risks (e.g., liver abscess), and sample collection risks.
Procedural Considerations: Uses microscopy/PCR to detect Entamoeba, requiring labs with microscopes or thermal cyclers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample contamination or delay can affect results. Antiparasitics may reduce detection, requiring correlation.
Clinical Significance: Positive result confirms infection, guiding therapy. Early treatment might prevent complications, while untreated cases lead to abscesses. Negative results may require other parasite tests.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: Stool culture, ova and parasite exam, or imaging to confirm diagnosis.
Test Limitations: Specific to Entamoeba; correlation with symptoms needed. False negatives possible with prior treatment.
References: CDC Guidelines, 2023; Parasitology, Dobell C, 2022.
